evidenceFinder is intended for health care professionals only.

The information found within this portal 1 includes:

  • Novo Nordisk sponsored real world studies in a US population 2 studying GLP-1 3 receptor agonists indicated for the treatment of adults with Type 2 Diabetes.
  • Phase 3 studies for Victoza ® (liraglutide injection) and Ozempic ® (semaglutide injection)

The website is owned and operated by Novo Nordisk and is intended for licensed Health Care Providers only. By clicking “Continue” below, you verify that you are a licensed health care provider and that you agree to the terms and conditions of this tool.

Request this article.

To request a copy of this study from the Medical Information department, please complete the form below. This form is for use by U.S. practicing healthcare providers only.

This site is not to be used to report adverse events or product complaints. To report an adverse event or product complaint, please call 1-800-727-6500.

I am not a Physician 2 or a licensed healthcare professional in MA, VT, or DC.
I approve the receipt of reportable article(s).
Please send ONLY non-reportable information.

This full article is a reportable item. To receive this article, please unselect the “Please send ONLY non-reportable information” radio button from your question form.

This full study is a reportable item. To receive this study, please unselect the “Please send ONLY non-reportable information” radio button from your question form.

1As required by the Sunshine Act, Novo Nordisk will disclose to the Federal government the value of certain educational materials including articles/reprints provided to Physicians and this information may be made publicly available by CMS. Novo Nordisk will also report similar information for healthcare professionals licensed to practice in those states with reporting requirements. 2Sunshine Act defines Physician as a licensed MD, DO, dentist, podiatrist, optometrist, or chiropractor.

Ask a Question.

To request information from the Medical Information department, please complete the form below. This form is for use by U.S. practicing healthcare providers only.

This site is not to be used to report adverse events or product complaints. To report an adverse event or product complaint, please call 1-800-727-6500.

I am not a Physician 2 or a licensed healthcare professional in MA, VT, or DC.
I approve the receipt of reportable article(s).
Please send ONLY non-reportable information.

This full study is a reportable item. To receive this study, please unselect the “Please send ONLY non-reportable information” radio button from your question form.

1As required by the Sunshine Act, Novo Nordisk will disclose to the Federal government the value of certain educational materials including articles/reprints provided to Physicians and this information may be made publicly available by CMS. Novo Nordisk will also report similar information for healthcare professionals licensed to practice in those states with reporting requirements. 2Sunshine Act defines Physician as a licensed MD, DO, dentist, podiatrist, optometrist, or chiropractor.
0
lives studied
0
articles
Sort our evidence library by evidence type, product and category. Select your areas of interest, view your results.
View Articles

Articles (0)

See additional information on PubMed